The opposite effect occurs in rodent models of Alzheimer’s disease, where disproportionate death of noradrenergic neurons causes increased expression of TNFα and iNOS, which can be reduced with norepinephrine administration [26]. Here, NOS2 is linked to early-onset autosomal dominant Alzheimer disease.